相关实验视频

Updated: Jun 16, 2025

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Generation of CAR T Cells for Adoptive Therapy in the Context of Glioblastoma Standard of Care

Published on: February 16, 2015

开发了用于治疗组合的输送系统,以改善收养细胞治疗

Fengfei Xu^1,2, Qiankun Ni^1,2,3, Ningqiang Gong⁴

¹CAS Key Laboratory for Biomedical Effects of Nanomaterials and Nanosafety, CAS Center for Excellence in Nanoscience, National Center for Nanoscience and Technology of China, Beijing, 100190, P.R. China.

Advanced materials (Deerfield Beach, Fla.)

|August 21, 2024

概括

采用细胞疗法 (ACT) 通过将细胞治疗与新的输送策略相结合,对固体瘤具有前景. 这些方法可以增强免疫细胞功能和瘤透,克服目前的局限性.

科学领域:

免疫学免疫学免疫学
在瘤学瘤学.
生物技术是生物技术.

背景情况:

采用细胞疗法 (ACT) 对血液癌症有效,但在固体瘤中面临挑战.
使用ACT治疗固体瘤是由于细胞扩张不良,疲劳,抗原损失和瘤密集的微环境而受到限制的.
目前的ACT策略很难克服这些固体瘤特异性障碍.

研究的目的:

审查在固体瘤中结合细胞疗法的输送策略的进展.
探索使用核酸输送的体内免疫细胞工程的潜力.
批判性地分析将传递技术与细胞疗法的整合带来的机遇和挑战.

主要方法:

对结合性细胞疗法用于固体瘤的传递策略的当前研究进行审查.
对研究的分析,研究了使用ACT的疫苗,抑制剂,细胞因子和化疗药物的输送.
核酸输送方法的评估,用于体内免疫细胞工程.

主要成果:

组合疗法改善了采用细胞的扩张,激活,并减少了疲劳.
输送策略增强了采用细胞透到固体瘤中的作用.
在体内输送核酸为复杂的体外细胞工程提供了一个有希望的替代方案.

结论:

交付策略对于提高实体瘤中ACT疗效至关重要.
将传递技术与ACT整合在一起,为癌症治疗提供了重大机会.
需要进一步的研究和开发来克服挑战,并充分发挥先进细胞疗法的潜力.

更多相关视频

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Automated Cell Enrichment of Cytomegalovirus-specific T cells for Clinical Applications using the Cytokine-capture System

Published on: October 5, 2015

A Spheroid Killing Assay by CAR T Cells

A Spheroid Killing Assay by CAR T Cells

Published on: December 12, 2018

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Combination Therapies and Personalized Medicine

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...